{rfName}

Indexat a

Llicència i ús

Altmetrics

Grant support

H.H. received support for the project PID2020-115439GB-I00 funded by MCIN/AEI/10.13039/501100011033. This publication is also supported as part of a project (BCLLATLAS and ESPACE) that has received funding from the European Research Council under the European Union's Horizon 2020 Research and Innovation Programme (grant agreement numbers 810287 and 874710). This work was supported by a European Research Council Consolidator grant to S.A. (724226_cis-CONTROL), KU Leuven (C14/22/125 to S.A.), Foundation Against Cancer (F/2020/1396 to S.A.), F.W.O. (grants G0I2722N, G0B5619N and G094121N to S.A. and a PhD fellowship to F.D.) and Aligning Science Across Parkinson's (grant number ASAP-000430 to S.A.). K.B.M. and S.A.T. are supported by Wellcome (WT211276/Z/18/Z and Sanger core grant WT206194). Computing was performed at the Vlaams Supercomputer Center and high-throughput sequencing at the Genomics Core Leuven. M.R.C. is supported by the National Institutes on Aging K99/R00AG059918. This work was supported by funding from the Rita Allen Foundation (W.J.G.) and the Human Frontiers Science Program (RGY006S; W.J.G.). W.J.G. is a Chan Zuckerberg Biohub investigator and acknowledges grants 2017-174468 and 2018-182817 from the Chan Zuckerberg Initiative and National Institutes of Health grants RM1-HG007735, UM1-HG009442, UM1-HG009436, R01-HG00990901 and U19-AI057266 (to W.J.G.). W.J.G. acknowledges funding from Emerson Collective. B.D. received financial support by Swiss National Science Foundation 310030_197082 and the EPFL. L.S.L. receives support from an Emmy Noether fellowship by the German Research Foundation (LU 2336/2-1), a National Institutes of Health grant UM1HG012076, a Longevity Impetus grant and a Hector Research Career Development Award by the Hector Fellow Academy. A.C.A. is supported by National Institutes of Health grants RF1-MH128842, R35-GM124704 and R01-DA047237 as well as a Silver Family Foundation Innovator Award.

Anàlisi d'autories institucional

Soler-Vila PAutor o coautorMartin-Subero JiAutor o coautor

Compartir

7 d’agost de 2023
Publicacions
>
Article
No

Systematic benchmarking of single-cell ATAC-sequencing protocols

Publicat a:Nature Biotechnology. 42 (6): 916-+ - 2024-06-01 42(6), DOI: 10.1038/s41587-023-01881-x

Autors: De Rop, Florian V; Hulselmans, Gert; Flerin, Chris; Soler-Vila, Paula; Rafels, Albert; Christiaens, Valerie; Gonzalez-Blas, Carmen Bravo; Marchese, Domenica; Caratu, Ginevra; Poovathingal, Suresh; Rozenblatt-Rosen, Orit; Slyper, Michael; Luo, Wendy; Muus, Christoph; Duarte, Fabiana; Shrestha, Rojesh; Bagdatli, S Tansu; Corces, M Ryan; Mamanova, Lira; Knights, Andrew; Meyer, Kerstin B; Mulqueen, Ryan; Taherinasab, Akram; Maschmeyer, Patrick; Pezoldt, Jörn; Lambert, Camille Lucie Germaine; Iglesias, Marta; Najle, Sebastian R; Dossani, Zain Y; Martelotto, Luciano G; Burkett, Zach; Lebofsky, Ronald; Martin-Subero, Jose Ignacio; Pillai, Satish; Sebe-Pedros, Arnau; Deplancke, Bart; Teichmann, Sarah A; Ludwig, Leif S; Braun, Theodore P; Greenleaf, William J; Buenrostro, Jason D; Regev, Aviv; Aerts, Stein; Heyn, Holger

Afiliacions

Adelaide Centre for Epigenetics and the South Australian Immunogenomics Cancer Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia. - Autor o coautor
Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, CNAG CRG, Barcelona, Spain - Autor o coautor
Berlin Inst Med Syst Biol BIMSB, Max Delbruck Ctr Mol Med Helmholtz Assoc MDC, Berlin, Germany - Autor o coautor
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany. - Autor o coautor
Bio Rad, Digital Biol Grp, Pleasanton, CA USA - Autor o coautor
Broad Inst & Harvard, Cambridge, MA USA - Autor o coautor
Broad Inst & MIT & Harvard, Gene Regulat Observ, Cambridge, MA USA - Autor o coautor
Broad Inst & MIT & Harvard, Klarman Cell Observ, Cambridge, MA USA - Autor o coautor
Broad Institute of MIT and Harvard, Cambridge, MA, USA. - Autor o coautor
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. - Autor o coautor
Chan Zuckerberg Biohub, San Francisco, CA USA - Autor o coautor
Chan Zuckerberg Biohub, San Francisco, CA, USA. - Autor o coautor
Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany - Autor o coautor
CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. - Autor o coautor
CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. holger.heyn@cnag.crg.eu. - Autor o coautor
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain - Autor o coautor
Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain. - Autor o coautor
Department of Genetics, Stanford University, Stanford, CA, USA. - Autor o coautor
Department of Human Genetics, KU Leuven, Leuven, Belgium. - Autor o coautor
Department of Human Genetics, KU Leuven, Leuven, Belgium. stein.aerts@kuleuven.be. - Autor o coautor
Department of Laboratory Medicine, University of California, San Francisco, CA, USA. - Autor o coautor
Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA. - Autor o coautor
Department of Physics/Cavendish Laboratory, University of Cambridge, Cambridge, UK. - Autor o coautor
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. - Autor o coautor
Digital Biology Group, Bio-Rad, Pleasanton, CA, USA. - Autor o coautor
Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Sciences University, Portland, OR, USA. - Autor o coautor
Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Sciences University, Portland, OR, USA. - Autor o coautor
Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Sch Life Sci, Lab Syst Biol & Genet, Lausanne, Switzerland - Autor o coautor
Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA. - Autor o coautor
Gladstone Inst Neurol Dis, San Francisco, CA USA - Autor o coautor
Gladstone Institute of Neurological Disease, San Francisco, CA, USA. - Autor o coautor
Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA USA - Autor o coautor
Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA. - Autor o coautor
ICREA, Barcelona, Spain - Autor o coautor
ICREA, Barcelona, Spain. - Autor o coautor
Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain - Autor o coautor
Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain - Autor o coautor
Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain. - Autor o coautor
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. - Autor o coautor
Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium - Autor o coautor
Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA. - Autor o coautor
Koch Inst Integrat Canc Res, Cambridge, MA USA - Autor o coautor
Koch Institute of Integrative Cancer Research, Cambridge, MA, USA. - Autor o coautor
Laboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. - Autor o coautor
Massachusetts Inst Technol MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA - Autor o coautor
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany. - Autor o coautor
Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR USA - Autor o coautor
Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR USA - Autor o coautor
Oregon Hlth & Sci Univ, Knight Canc Inst, Div Oncol Sci, Portland, OR USA - Autor o coautor
Stanford Univ, Dept Genet, Stanford, CA USA - Autor o coautor
Swiss Inst Bioinformat SIB, Lausanne, Switzerland - Autor o coautor
Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland. - Autor o coautor
Univ Adelaide, Adelaide Ctr Epigenet, Fac Hlth & Med Sci, Adelaide, SA, Australia - Autor o coautor
Univ Adelaide, South Australian Immunogen Canc Inst, Fac Hlth & Med Sci, Adelaide, SA, Australia - Autor o coautor
Univ Barcelona, Dept Fonaments Clin, Fac Med, Barcelona, Spain - Autor o coautor
Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA - Autor o coautor
Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England - Autor o coautor
Univ Melbourne, Victoria Comprehens Canc Ctr, Ctr Canc Res, Melbourne, Vic, Australia - Autor o coautor
Univ Pompeu Fabra UPF, Barcelona, Spain - Autor o coautor
Universitat Pompeu Fabra (UPF), Barcelona, Spain. - Autor o coautor
Universitat Pompeu Fabra (UPF), Barcelona, Spain. holger.heyn@cnag.crg.eu. - Autor o coautor
University of Melbourne Centre for Cancer Research, Victoria Comprehensive Cancer Centre, Melbourne, Victoria, Australia. - Autor o coautor
VIB Center for Brain and Disease Research, Leuven, Belgium. - Autor o coautor
VIB Center for Brain and Disease Research, Leuven, Belgium. stein.aerts@kuleuven.be. - Autor o coautor
VIB Ctr Brain & Dis Res, Leuven, Belgium - Autor o coautor
Vitalant Res Inst, San Francisco, CA USA - Autor o coautor
Vitalant Research Institute, San Francisco, CA, USA. - Autor o coautor
Wellcome Sanger Inst, Cambridge, England - Autor o coautor
Wellcome Sanger Institute, Cambridge, UK. - Autor o coautor
Veure més

Resum

Single-cell assay for transposase-accessible chromatin by sequencing (scATAC-seq) has emerged as a powerful tool for dissecting regulatory landscapes and cellular heterogeneity. However, an exploration of systemic biases among scATAC-seq technologies has remained absent. In this study, we benchmark the performance of eight scATAC-seq methods across 47 experiments using human peripheral blood mononuclear cells (PBMCs) as a reference sample and develop PUMATAC, a universal preprocessing pipeline, to handle the various sequencing data formats. Our analyses reveal significant differences in sequencing library complexity and tagmentation specificity, which impact cell-type annotation, genotype demultiplexing, peak calling, differential region accessibility and transcription factor motif enrichment. Our findings underscore the importance of sample extraction, method selection, data processing and total cost of experiments, offering valuable guidance for future research. Finally, our data and analysis pipeline encompasses 169,000 PBMC scATAC-seq profiles and a best practices code repository for scATAC-seq data analysis, which are freely available to extend this benchmarking effort to future protocols.© 2023. The Author(s).

Paraules clau

Analysis protocolArticleAutoanalysisBenchmarkingCell typesCells by body anatomyCellularsChromatinChromatin immunoprecipitation sequencingControlled studyCytologyData analysisData handlingDna sequencingExtractionGene expressionGeneticsGenotypeHigh throughput sequencingHigh-throughput nucleotide sequencingHumanHuman cellHuman peripheral bloodHumansLeukocytes, mononuclearMononuclear cellPerformancePeripheral blood mononuclear cellPeripheral blood mononuclear cellsPipelinePipelinesProceduresSensitivity and specificitySequence analysis, dnaSequencing methodSex differenceSingle cell analysisSingle cell assaysSingle cellsSingle-cell analysisSmall cytoplasmic rnaTranscriptionTranscription factorTransposaseTransposasesType annotations

Indicis de qualitat

Impacte bibliomètric. Anàlisi de la contribució i canal de difusió

El treball ha estat publicat a la revista Nature Biotechnology a causa de la seva progressió i el bon impacte que ha aconseguit en els últims anys, segons l'agència WoS (JCR), s'ha convertit en una referència en el seu camp. A l'any de publicació del treball, 2024 encara no hi ha indicis calculats, però el 2023, es trobava a la posició 2/177, aconseguint així situar-se com a revista Q1 (Primer Cuartil), en la categoria Biotechnology & Applied Microbiology. Destacable, igualment, el fet que la revista està posicionada per sobre del Percentil 90.

Des d'una perspectiva relativa, i atenent a l'indicador de impacte normalitzat calculat a partir del Field Citation Ratio (FCR) de la font Dimensions, proporciona un valor de: 14.15, el que indica que, comparat amb treballs en la mateixa disciplina i en el mateix any de publicació, el situa com un treball citat per sobre de la mitjana. (font consultada: Dimensions Aug 2025)

Concretament, i atenent a les diferents agències d'indexació, aquest treball ha acumulat, fins a la data 2025-08-10, el següent nombre de cites:

  • WoS: 14
  • Scopus: 11
  • Europe PMC: 8

Impacte i visibilitat social

Des de la dimensió d'influència o adopció social, i prenent com a base les mètriques associades a les mencions i interaccions proporcionades per agències especialitzades en el càlcul de les denominades "Mètriques Alternatives o Socials", podem destacar a data 2025-08-10:

  • L'ús, des de l'àmbit acadèmic evidenciat per l'indicador de l'agència Altmetric referit com a agregacions realitzades pel gestor bibliogràfic personal Mendeley, ens dona un total de: 127.
  • L'ús d'aquesta aportació en marcadors, bifurcacions de codi, afegits a llistes de favorits per a una lectura recurrent, així com visualitzacions generals, indica que algú està fent servir la publicació com a base del seu treball actual. Això pot ser un indicador destacat de futures cites més formals i acadèmiques. Aquesta afirmació està avalada pel resultat de l'indicador "Capture", que aporta un total de: 127 (PlumX).

Amb una intenció més de divulgació i orientada a audiències més generals, podem observar altres puntuacions més globals com:

  • El Puntuació total de Altmetric: 160.15.
  • El nombre de mencions a la xarxa social Facebook: 2 (Altmetric).
  • El nombre de mencions a la xarxa social X (abans Twitter): 293 (Altmetric).

Anàlisi del lideratge dels autors institucionals

Aquest treball s'ha realitzat amb col·laboració internacional, concretament amb investigadors de: Australia; Belgium; Germany; Switzerland; United Kingdom; United States of America.